ZA959362B - Carbocyclic compounds - Google Patents

Carbocyclic compounds

Info

Publication number
ZA959362B
ZA959362B ZA959362A ZA959362A ZA959362B ZA 959362 B ZA959362 B ZA 959362B ZA 959362 A ZA959362 A ZA 959362A ZA 959362 A ZA959362 A ZA 959362A ZA 959362 B ZA959362 B ZA 959362B
Authority
ZA
South Africa
Prior art keywords
carbocyclic compounds
carbocyclic
compounds
Prior art date
Application number
ZA959362A
Other languages
English (en)
Inventor
Jose Ramon Ruiz Gomez
Jose Maria Bueno Calderon
Silvestre Garcia-Ochoa Dorado
Maria Teresa Fraile Gabaldon
Julia Castro Pichel
Jose Fiandor Roman
Domingo Gargallo Viola
Juan Carlos Cuevas Zurita
Jose Luis Lavandera Diaz
Sophie Huss
Original Assignee
Glaxo Wellcome Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP94500175A external-priority patent/EP0711784A1/en
Priority claimed from EP94500173A external-priority patent/EP0712859A1/en
Application filed by Glaxo Wellcome Sa filed Critical Glaxo Wellcome Sa
Publication of ZA959362B publication Critical patent/ZA959362B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/24—Condensed ring systems having three or more rings
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02—Oxygen as only ring hetero atoms
    • C12P17/06—Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/44—Preparation of O-glycosides, e.g. glucosides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA959362A 1994-11-08 1995-11-06 Carbocyclic compounds ZA959362B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP94500175A EP0711784A1 (en) 1994-11-08 1994-11-08 Antifungal Sordarin derivatives
EP94500173A EP0712859A1 (en) 1994-11-08 1994-11-08 Antifungal Sordarin derivatives

Publications (1)

Publication Number Publication Date
ZA959362B true ZA959362B (en) 1996-05-08

Family

ID=26137608

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA959362A ZA959362B (en) 1994-11-08 1995-11-06 Carbocyclic compounds

Country Status (35)

Country Link
US (2) US5854280A (es)
EP (1) EP0753001B1 (es)
JP (1) JPH09508144A (es)
KR (1) KR100391401B1 (es)
CN (1) CN1056849C (es)
AP (1) AP614A (es)
AR (1) AR013815A1 (es)
AT (1) ATE184284T1 (es)
AU (1) AU704405B2 (es)
BG (1) BG62620B1 (es)
BR (1) BR9506473A (es)
CA (1) CA2179403A1 (es)
CO (1) CO4520226A1 (es)
CZ (1) CZ202796A3 (es)
DE (1) DE69512041T2 (es)
DK (1) DK0753001T3 (es)
EE (1) EE9600117A (es)
ES (1) ES2137549T3 (es)
FI (1) FI962773A (es)
GR (1) GR3031677T3 (es)
HK (1) HK1004222A1 (es)
HU (1) HU218611B (es)
IL (1) IL115905A0 (es)
IS (1) IS4352A (es)
MX (1) MX9602563A (es)
NO (1) NO307092B1 (es)
NZ (1) NZ296091A (es)
OA (1) OA10303A (es)
PE (1) PE49696A1 (es)
RU (1) RU2152398C1 (es)
SI (1) SI0753001T1 (es)
SK (1) SK88496A3 (es)
TW (1) TW321644B (es)
WO (1) WO1996014326A1 (es)
ZA (1) ZA959362B (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0901493A1 (en) * 1996-05-08 1999-03-17 Glaxo Wellcome S.A. Process for the preparation of an indacene compound
US6436395B1 (en) * 1996-09-18 2002-08-20 Merck & Co., Inc. Rosellinia subiculata ATCC 74386 and fungus ATCC 74387 for producing sordarin compounds for fungi control
US6040463A (en) * 1996-10-07 2000-03-21 Merck & Co., Inc. Sordarin derivatives
US6096511A (en) * 1997-06-10 2000-08-01 Merck & Co., Inc. Protein elongation factor 2 as a target for antifungal and antiparasitic agents
US5965612A (en) * 1997-08-22 1999-10-12 Merck & Co., Inc. 4-cyano-4-deformylsordaricin derivatives
ES2198064T3 (es) * 1997-08-22 2004-01-16 MERCK & CO., INC. Derivados de 4-ciano-4-deformilsordarina.
US5972996A (en) * 1997-08-22 1999-10-26 Merck & Co., Inc. 4-cyano-4-deformylsordarin derivatives
US6136853A (en) * 1997-10-03 2000-10-24 Merck & Co., Inc. Sordarin derivatives
FI974385A0 (fi) * 1997-12-01 1997-12-01 Xyrofin Oy Anvaendning av xylitol foer bekaempning av jaestinfektion och xylitolpreparat foer denna anvaendning
US7070965B1 (en) * 1998-04-14 2006-07-04 Zhenhua Yang Small molecule anticancer compounds and related production process
MA26628A1 (fr) * 1998-05-11 2004-12-20 Glaxo Wellcome Sa Morpholino ethers
JP2002528444A (ja) 1998-10-26 2002-09-03 メルク エンド カムパニー インコーポレーテッド 微生物変換産物
EP1191948A2 (en) 1999-06-11 2002-04-03 Neorx Corporation High dose radionuclide complexes for bone marrow suppression
US7094885B2 (en) 1999-07-11 2006-08-22 Neorx Corporation Skeletal-targeted radiation to treat bone-associated pathologies
WO2001034583A1 (en) * 1999-11-11 2001-05-17 Glaxo Wellcome Sa Antifungal sordaricin derivatives
WO2002022567A1 (en) * 2000-09-15 2002-03-21 Bristol-Myers Squibb Company Novel thio derivatives of sordarin as antifungal agents
JP2004536034A (ja) * 2001-01-08 2004-12-02 ネオルクス コーポレイション 治療的および診断的化合物、組成物および方法
WO2003007878A2 (en) 2001-07-18 2003-01-30 Merck & Co., Inc. Antifungal agents of sordarin derivatives
JP2005516933A (ja) 2001-12-13 2005-06-09 ダウ グローバル テクノロジーズ インコーポレイティド 放射性医薬による骨髄炎の治療
US20040242904A1 (en) * 2001-12-14 2004-12-02 Angelo Basilio Novel sordarin derivative isolated from culture fermentations and functions as an antifungal agent
TW200503781A (en) * 2002-12-31 2005-02-01 Nektar Therapeutics Aerosolizable pharmaceutical formulation for fungal infection therapy
US9314524B2 (en) 2007-12-31 2016-04-19 Calla Therapeutics Llc Topical formulations of Flucytosine
US8419948B2 (en) * 2009-11-22 2013-04-16 United Laboratories International, Llc Wastewater treatment
WO2012033427A1 (ru) * 2010-09-08 2012-03-15 Dalin Mikhail Viktorovich Способ лечения микотических инфекций и препарат для его осуществления
RU2630403C2 (ru) * 2016-02-25 2017-09-07 Жанна Владимировна Вараткова Абразивная масса для изготовления инструмента с высокими номерами структуры

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH465771A (de) * 1965-12-06 1968-11-30 Sandoz Ag Verfahren zur Herstellung eines neuen Antibioticums
JPH0615555B2 (ja) * 1985-08-14 1994-03-02 三共株式会社 抗生物質ゾフイマリン
JP3189443B2 (ja) * 1992-11-20 2001-07-16 萬有製薬株式会社 抗真菌性物質ｂｅ−３１４０５
CA2265824C (en) * 1996-09-12 2004-11-09 Merck & Co., Inc. Antifungal combination therapy

Also Published As

Publication number Publication date
ATE184284T1 (de) 1999-09-15
CN1143965A (zh) 1997-02-26
GR3031677T3 (en) 2000-02-29
CN1056849C (zh) 2000-09-27
MX9602563A (es) 1997-05-31
CZ202796A3 (en) 1997-02-12
DE69512041T2 (de) 2000-02-03
CA2179403A1 (en) 1996-05-17
AP9600824A0 (en) 1996-07-31
DK0753001T3 (da) 2000-05-08
KR100391401B1 (ko) 2003-12-31
BR9506473A (pt) 1997-10-07
AU3980995A (en) 1996-05-31
FI962773A0 (fi) 1996-07-05
NO307092B1 (no) 2000-02-07
AU704405B2 (en) 1999-04-22
BG62620B1 (en) 2000-03-31
FI962773A (fi) 1996-08-26
CO4520226A1 (es) 1997-10-15
US5952334A (en) 1999-09-14
ES2137549T3 (es) 1999-12-16
IS4352A (is) 1996-06-10
RU2152398C1 (ru) 2000-07-10
JPH09508144A (ja) 1997-08-19
US5854280A (en) 1998-12-29
NO962856D0 (no) 1996-07-05
DE69512041D1 (de) 1999-10-14
SK88496A3 (en) 1997-04-09
IL115905A0 (en) 1996-01-31
NZ296091A (en) 1998-06-26
EE9600117A (et) 1997-04-15
HUT76292A (en) 1997-07-28
HK1004222A1 (en) 1998-11-20
AP614A (en) 1997-09-05
SI0753001T1 (en) 1999-12-31
WO1996014326A1 (en) 1996-05-17
BG100699A (bg) 1997-02-28
HU9601865D0 (en) 1996-11-28
EP0753001A1 (en) 1997-01-15
AR013815A1 (es) 2001-01-31
PE49696A1 (es) 1996-12-05
NO962856L (no) 1996-09-05
OA10303A (en) 1997-10-07
TW321644B (es) 1997-12-01
HU218611B (hu) 2000-10-28
EP0753001B1 (en) 1999-09-08

Similar Documents

Publication Publication Date Title
GB9407812D0 (en) Compounds
GB9414193D0 (en) Compounds
GB9414208D0 (en) Compounds
ZA959362B (en) Carbocyclic compounds
GB9404706D0 (en) Compounds
GB9406043D0 (en) Compounds
GB9407435D0 (en) Compounds
GB9403199D0 (en) Compounds
GB9400413D0 (en) Compounds
GB9417938D0 (en) Compounds
GB9402197D0 (en) Compounds
GB9402041D0 (en) Compounds
GB9410035D0 (en) Compounds
GB9402603D0 (en) Compounds
GB2296241B (en) Compounds
GB9402196D0 (en) Compounds
GB9407510D0 (en) Compounds
GB9406182D0 (en) Compounds
GB9406181D0 (en) Compounds
GB9420060D0 (en) Compounds
GB9420057D0 (en) Compounds
GB9413233D0 (en) Compounds
GB9409887D0 (en) Compounds
GB9420047D0 (en) Compounds
GB9409876D0 (en) Compounds